Vimab Group AB (publ) (STO:VIMAB)
Sweden · Delayed Price · Currency is SEK 2.680
+0.080 (3.08%)
At close: Jun 18, 2026
Vimab Group AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 332.18 | 318.19 | 325.29 | 342.35 | 227.29 | 205.68 |
| 332.18 | 318.19 | 325.29 | 342.35 | 227.29 | 205.68 | |
Revenue Growth (YoY) | 5.99% | -2.18% | -4.98% | 50.63% | 10.51% | -5.15% |
Cost of Revenue | 276.55 | 269.44 | 245.27 | 233.02 | 164.35 | 157.04 |
Gross Profit | 55.63 | 48.75 | 80.02 | 109.33 | 62.94 | 48.64 |
Selling, General & Admin | 81.25 | 80 | 97.4 | 83.56 | 57.41 | 56.02 |
Other Operating Expenses | 14.45 | 12.14 | -1.09 | -1.09 | -1.08 | -2.89 |
Operating Expenses | 136.64 | 134.1 | 159.51 | 107.65 | 77.11 | 70 |
Operating Income | -81.01 | -85.35 | -79.49 | 1.69 | -14.17 | -21.35 |
Interest Expense | -22.25 | -22.51 | -7.47 | -9.2 | -2.44 | -4.82 |
Interest & Investment Income | - | 0.04 | 0.12 | 3.98 | 0.08 | 3.9 |
Earnings From Equity Investments | - | - | - | -7.01 | - | - |
Currency Exchange Gain (Loss) | - | 0.29 | 1.82 | 1.93 | 0.46 | - |
Other Non Operating Income (Expenses) | 10.1 | -1.89 | -1.28 | 0.3 | - | - |
EBT Excluding Unusual Items | -93.16 | -109.43 | -86.29 | -8.31 | -16.07 | -22.27 |
Gain (Loss) on Sale of Investments | - | -0.01 | -0.03 | - | - | -2.49 |
Gain (Loss) on Sale of Assets | - | 1.39 | 0.74 | 3.06 | - | 0.12 |
Other Unusual Items | - | 5.87 | - | - | -15.75 | - |
Pretax Income | -93.16 | -102.18 | -85.58 | -5.25 | -31.82 | -24.64 |
Income Tax Expense | -0.5 | -0.5 | -0.76 | 1.16 | 2.4 | -0.56 |
Earnings From Continuing Operations | -92.66 | -101.68 | -84.82 | -6.41 | -34.22 | -24.09 |
Minority Interest in Earnings | - | - | 7.88 | 2.15 | - | - |
Net Income | -92.66 | -101.68 | -76.94 | -4.26 | -34.22 | -24.09 |
Net Income to Common | -92.66 | -101.68 | -76.94 | -4.26 | -34.22 | -24.09 |
Shares Outstanding (Basic) | 31 | 26 | 23 | 21 | 10 | 3 |
Shares Outstanding (Diluted) | 31 | 26 | 23 | 21 | 10 | 3 |
Shares Change (YoY) | 27.64% | 12.12% | 10.99% | 110.97% | 265.91% | - |
EPS (Basic) | -3.03 | -3.90 | -3.31 | -0.20 | -3.44 | -8.87 |
EPS (Diluted) | -3.03 | -3.90 | -3.31 | -0.20 | -3.44 | -8.87 |
Free Cash Flow | -56.2 | -22 | -0.58 | 6.4 | 1.21 | -8.58 |
Free Cash Flow Per Share | -1.84 | -0.84 | -0.03 | 0.30 | 0.12 | -3.16 |
Gross Margin | 16.75% | 15.32% | 24.60% | 31.94% | 27.69% | 23.65% |
Operating Margin | -24.39% | -26.82% | -24.44% | 0.49% | -6.23% | -10.38% |
Profit Margin | -27.89% | -31.95% | -23.65% | -1.24% | -15.06% | -11.71% |
Free Cash Flow Margin | -16.92% | -6.91% | -0.18% | 1.87% | 0.53% | -4.17% |
EBITDA | -40.07 | -55.73 | -16.31 | 26.86 | 5.62 | -3.17 |
EBITDA Margin | -12.06% | -17.51% | -5.01% | 7.85% | 2.47% | -1.54% |
D&A For EBITDA | 40.94 | 29.63 | 63.18 | 25.18 | 19.78 | 18.19 |
EBIT | -81.01 | -85.35 | -79.49 | 1.69 | -14.17 | -21.35 |
EBIT Margin | -24.39% | -26.82% | -24.44% | 0.49% | -6.23% | -10.38% |
Revenue as Reported | 342.28 | 328.64 | 330.25 | 347.82 | 229.25 | 209.04 |